Trials / Unknown
UnknownNCT02178319
Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled Trial
Randomized Clinical Trial Comparing Laparoscopic and Open Esophagogastric Devascularization and Splenectomy for Portal Hypertension
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Many patients with portal hypertension require surgical treatment each year,and Hassab's operation, or esophagogastric devascularization and splenectomy, is an elective procedure. In recent years,laparoscopic esophagogastric devascularization and splenectomy has been used to treat portal hypertension. However, the potential benefits remain to be demonstrated in the context of a randomized trial. In this study, 120 patients will randomize equally receiving laparoscopic or open esophagogastric devascularization and splenectomy. Inclusion criteria included: platelet count \< 50×109/ml, esophageal and gastric varices revealed, agreeing the informed consent. PerioperativeOutcomes are: technical success, blood loose and infusion during the operation, recurrent varicose veins on gastroscopy examination, patterns of reflux on duplex ultrasound examination, complications, platelet and liver function variation, length of hospital stay. Follow-up will last 5 years, and gastroscopy and ultrasonic will perform at 3 months, 1 year, 3 years, and 5 years. Further more, this study was proved by the ethical committee of second hospital of Xi'an jiaotong university.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | open surgical procedure | open esophagogastric devascularization and splenectomy will perform as surgical procedure in the patients |
| PROCEDURE | laparoscopic surgical procedure | laparoscopic esophagogastric devascularization and splenectomy will perform as surgical procedure in the patients |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2021-06-01
- Completion
- 2021-09-01
- First posted
- 2014-06-30
- Last updated
- 2014-06-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02178319. Inclusion in this directory is not an endorsement.